TRCT
BHC icon

Tower Research Capital (TRC)’s Bausch Health BHC Stock Holding History

Tower Research Capital (TRC)’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.24K Sell
600
-2,428
-80% -$14.5K ﹤0.01% 4348
2025
Q4 		$21K Sell
3,028
-3,995
-57% -$26.3K ﹤0.01% 3066
2025
Q3 		$45.3K Buy
7,023
+3,392
+93% +$23.2K ﹤0.01% 2601
2025
Q2 		$24.2K Buy
3,631
+45
+1% +$231 ﹤0.01% 3573
2025
Q1 		$23.2K Buy
3,586
+922
+35% +$6.62K ﹤0.01% 2823
2024
Q4 		$21.5K Sell
2,664
-12,919
-83% -$107K ﹤0.01% 3134
2024
Q3 		$127K Buy
15,583
+12,620
+426% +$83.2K ﹤0.01% 2041
2024
Q2 		$20.7K Buy
2,963
+88
+3% +$666 ﹤0.01% 3751
2024
Q1 		$30.5K Sell
2,875
-4,043
-58% -$35.4K ﹤0.01% 2638
2023
Q4 		$55.5K Buy
6,918
+5,112
+283% +$37.2K ﹤0.01% 3061
2023
Q3 		$14.8K Sell
1,806
-10,262
-85% -$88.5K ﹤0.01% 3654
2023
Q2 		$96.5K Buy
12,068
+11,068
+1,107% +$81.6K ﹤0.01% 2041
2023
Q1 		$8K Sell
1,000
-26,980
-96% -$217K ﹤0.01% 4609
2022
Q4 		$176K Sell
27,980
-28,861
-51% -$202K 0.01% 1388
2022
Q3 		$396K Buy
56,841
+19,804
+53% +$138K 0.01% 1318
2022
Q2 		$310K Sell
37,037
-27,604
-43% -$386K 0.01% 1454
2022
Q1 		$1.48M Buy
64,641
+45,921
+245% +$1.12M 0.01% 655
2021
Q4 		$514K Buy
18,720
+114
+0.6% +$3.05K 0.01% 1093
2021
Q3 		$515K Sell
18,606
-3,862
-17% -$110K 0.01% 965
2021
Q2 		$659K Buy
22,468
+1,363
+6% +$41.3K 0.02% 957
2021
Q1 		$666K Buy
21,105
+1,899
+10% +$55.7K 0.01% 1005
2020
Q4 		$398K Sell
19,206
-17,757
-48% -$331K 0.01% 1170
2020
Q3 		$572K Buy
36,963
+17,006
+85% +$293K 0.01% 1540
2020
Q2 		$365K Sell
19,957
-15,296
-43% -$270K 0.02% 1278
2020
Q1 		$547K Buy
35,253
+16,747
+90% +$404K 0.03% 402
2019
Q4 		$550K Sell
18,506
-20,645
-53% -$537K 0.05% 238
2019
Q3 		$855K Buy
39,151
+18,445
+89% +$422K 0.06% 340
2019
Q2 		$523K Buy
20,706
+14,601
+239% +$347K 0.04% 449
2019
Q1 		$150K Sell
6,105
-6,006
-50% -$143K 0.01% 1246
2018
Q4 		$224K Buy
12,111
+10,151
+518% +$241K 0.02% 650
2018
Q3 		$50K Sell
1,960
-1,580
-45% -$36.2K ﹤0.01% 1755
2018
Q2 		$82K Buy
3,540
+1,645
+87% +$34K ﹤0.01% 1559
2018
Q1 		$31K Sell
1,895
-1,077
-36% -$20K ﹤0.01% 1948
2017
Q4 		$78K Sell
2,972
-6,391
-68% -$101K 0.01% 1025
2017
Q3 		$168K Buy
9,363
+8,363
+836% +$126K 0.01% 890
2017
Q2 		$23K Buy
1,000
+900
+900% +$10.8K ﹤0.01% 1135
2017
Q1 		$1K Sell
100
-1,034
-91% -$14.2K ﹤0.01% 2760
2016
Q4 		$16K Sell
1,134
-20,064
-95% -$368K ﹤0.01% 2322
2016
Q3 		$520K Buy
21,198
+14,793
+231% +$383K 0.05% 156
2016
Q2 		$129K Buy
6,405
+402
+7% +$11.4K 0.01% 949
2016
Q1 		$158K Buy
6,003
+2,893
+93% +$214K 0.02% 376
2015
Q4 		$316K Sell
3,110
-331
-10% -$37.2K 0.05% 144
2015
Q3 		$819K Buy
3,441
+1,741
+102% +$406K 0.08% 126
2015
Q2 		$378K Sell
1,700
-7,089
-81% -$1.57M 0.03% 185
2015
Q1 		$2.2M Buy
8,789
+8,162
+1,302% +$1.45M 0.27% 54
2014
Q4 		$89K Sell
627
-933
-60% -$125K 0.01% 745
2014
Q3 		$229K Buy
1,560
+712
+84% +$84.9K 0.03% 478
2014
Q2 		$107K Sell
848
-15,207
-95% -$1.94M 0.01% 866
2014
Q1 		$2.12M Buy
16,055
+16,041
+114,579% +$2.19M 0.27% 68
2013
Q4 		$2K Sell
14
-280
-95% -$30.7K ﹤0.01% 3973
2013
Q3 		$31K Sell
294
-6,430
-96% -$626K ﹤0.01% 2323
2013
Q2 		$610K Buy
+6,724
New +$530K 0.05% 110

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tower Research Capital (TRC)'s BHC Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Bausch Health (BHC) stake by 80% in Q1 2026, selling an estimated $14.5K and leaving 600 shares worth $3.24K. The position accounts for ﹤0.01% of the portfolio, ranked #4348.

Tower Research Capital (TRC) first reported a position in BHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.2M in Q1 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Tower Research Capital (TRC) held 600 shares of Bausch Health worth $3.24K as of Q1 2026.
  • Tower Research Capital (TRC) sold 2,428 Bausch Health shares in Q1 2026, an estimated $14.5K.
  • Bausch Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4348 holding.
  • Tower Research Capital (TRC) first reported a position in Bausch Health in Q2 2013 and has held it in 52 quarters since.
  • Tower Research Capital (TRC)'s Bausch Health position peaked at $2.2M in Q1 2015.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.